Application
19507141 · COMPOSITIONS AND METHODS FOR TREATING CANCERS WITH HLA-A*03 LOSS OF EXPRESSION
Filed 2026-01-30 · Pending The official file ↗ · Art unit · A2 Biotherapeutics, Inc. · Mintz Levin/Special Group
Office actions
0
first was
RCEs
0
no appeal
To first action
n/a
to disposition n/a
Statutes raised
·
0 actions read